NASDAQ:RGC | Income Statement | Regencell Bioscience Holdings Ltd

Complete source-backed income-statement history.

Available history
2019-06-30 to 2025-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-06-30$948,289.00$3.77M-$3.77M-$3.58M-$3.58M-$0.72-$0.72494,488,908494,488,908
2024-06-30$1.07M$4.74M-$4.74M-$4.36M-$4.3M-$0.87-$0.87494,488,908494,488,908
2023-06-30$1.58M$6.27M-$6.27M-$6.06M-$5.87M-$1.19-$1.19494,488,908494,488,908
2022-06-30$2.51M$7.62M-$7.62M-$7.59M-$7.45M-$0.58-$0.5812,805,70712,805,707
2021-06-30$438,323.00$1.38M-$1.38M-$1.35M-$1.35M$0.13-$0.1310,000,00010,000,000
2020-06-30$386,230.00$812,371.00-$812,371.00-$812,371.00-$812,371.00$0.08-$0.0810,000,00010,000,000
2019-06-30$228,223.00$390,990.00-$390,990.00-$390,990.00-$390,990.000.0410,000,000

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.